Although upfront IL-6 blockade has been shown to mitigate experimental autoimmune encephalomyelitis symptoms109, no pre-clinical models have been reported that mimic the timing of immunosuppression in the context of irAEs in which IL-6 blockade is initiated after ICI. Here, IL6 is linked to experimental autoimmune encephalomyelitis.